CAPTRUST FINANCIAL ADVISORS - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$9,100
-32.1%
20,0000.0%0.00%
Q2 2023$13,400
+55.8%
20,0000.0%0.00%
Q1 2023$8,600
-28.3%
20,0000.0%0.00%
Q3 2022$12,000
-25.0%
20,0000.0%0.00%
Q2 2022$16,000
-23.8%
20,0000.0%0.00%
Q1 2022$21,000
+16.7%
20,0000.0%0.00%
Q4 2021$18,000
-55.0%
20,0000.0%0.00%
Q3 2021$40,000
-7.0%
20,0000.0%0.00%
Q2 2021$43,000
+34.4%
20,000
+42.9%
0.00%
Q1 2021$32,000
+77.8%
14,000
+40.0%
0.00%
Q4 2020$18,00010,0000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q1 2021
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders